Fetzima 40 mg/1

Fetzima 40 mg is an extended-release capsule containing levomilnacpran hydrochloride, used for managing depressive disorders. This medication is designed to provide sustained relief and is manufactured by Allergan, Inc.

Fetzima 40 mg is primarily used for the management of major depressive disorder (MDD). It works by affecting the balance of certain natural substances in the brain. People often ask, 'What is Fetzima used for?' and the answer is that it is typically prescribed to help alleviate symptoms of depression, such as persistent sadness, loss of interest, and changes in sleep or appetite.

Common effects of Fetzima 40 mg may include nausea, dry mouth, and increased sweating. Some users also report constipation, decreased appetite, and dizziness. These effects can vary from person to person and may subside as the body adjusts to the medication.

Fetzima 40 mg should be handled with care. It is important to follow the prescribed dosage and not to crush or chew the extended-release capsules. Always consult a healthcare provider before starting or stopping this medication, especially if you have a history of heart, liver, or kidney problems.

Fetzima 40 mg may interact with other medications, including those that affect serotonin levels, such as SSRIs and SNRIs. It is also important to be cautious when consuming alcohol or using other central nervous system depressants. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.